AHSV VP2 is the major outer capsid protein of the African horse sickness virus (AHSV) and is the primary target for neutralizing antibodies, making it a critical component for vaccine development. VP2 determines the AHSV serotype, with the virus classified into nine serotypes based on VP2's antigenicity. It's responsible for cell attachment and entry during infection and is an important target for serotype-specific immunity.
Keywords
African horse sickness virus; AHSV; AHSV VP2
Citations
Publication ()
Have you cited DAGC-H014 in a publication? Let us know and earn a reward for your research.
My Review for Recombinant AHSV-1 VP2 Protein [His]
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
